• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

δ 型阿片受体激动剂可改变 μ 型阿片受体激动剂与 μ-δ 型受体异源寡聚体的结合。

Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.

机构信息

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

出版信息

Br J Pharmacol. 2010 Nov;161(5):1122-36. doi: 10.1111/j.1476-5381.2010.00944.x.

DOI:10.1111/j.1476-5381.2010.00944.x
PMID:20977461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2998692/
Abstract

BACKGROUND AND PURPOSE

µ- and δ-opioid receptors form heteromeric complexes with unique ligand binding and G protein-coupling profiles linked to G protein α z-subunit (Gα(z) ) activation. However, the mechanism of action of agonists and their regulation of the µ-δ receptor heteromer are not well understood.

EXPERIMENTAL APPROACH

Competition radioligand binding, cell surface receptor internalization in intact cells, confocal microscopy and receptor immunofluorescence techniques were employed to study the regulation of the µ-δ receptor heteromer in heterologous cells with and without agonist exposure.

KEY RESULTS

Gα(z) enhanced affinity of some agonists at µ-δ receptor heteromers, independent of agonist chemical structure. δ-Opioid agonists displaced µ-agonist binding with high affinity from µ-δ heteromers, but not µ receptor homomers, suggestive of δ-agonists occupying a novel µ-receptor ligand binding pocket within the heteromers. Also, δ-agonists induced internalization of µ-opioid receptors in cells co-expressing µ- and δ-receptors, but not those expressing µ-receptors alone, indicative of µ-δ heteromer internalization. This dose-dependent, Pertussis toxin-resistant and clathrin- and dynamin-dependent effect required agonist occupancy of both µ- and δ-opioid receptors. In contrast to µ-receptor homomers, agonist-induced internalization of µ-δ heteromers persisted following chronic morphine exposure.

CONCLUSIONS AND IMPLICATIONS

The µ-δ receptor heteromer may contain a novel δ-agonist-detected, high-affinity, µ-receptor ligand binding pocket and is regulated differently from the µ-receptor homomer following chronic morphine exposure. Occupancy of both µ- and δ-receptor binding pockets is required for δ-agonist-induced endocytosis of µ-δ receptor heteromers. δ-Opioid agonists target µ-δ receptor heteromers, and thus have a broader pharmacological specificity than previously identified.

摘要

背景与目的

μ 型和 δ 型阿片受体与独特的配体结合和 G 蛋白偶联特性形成异源二聚体,与 G 蛋白 αz 亚基(Gα(z))的激活有关。然而,激动剂的作用机制及其对 μ-δ 受体异源二聚体的调节尚不清楚。

实验方法

采用竞争放射配体结合、完整细胞表面受体内化、共聚焦显微镜和受体免疫荧光技术,研究了在有和没有激动剂暴露的情况下,异源细胞中 μ-δ 受体异源二聚体的调节。

主要结果

Gα(z)增强了一些激动剂在 μ-δ 受体异源二聚体中的亲和力,而与激动剂的化学结构无关。δ 型阿片受体激动剂以高亲和力从 μ-δ 异源二聚体中置换 μ 型激动剂结合,但不置换 μ 受体同源二聚体,提示 δ 型激动剂占据了异源二聚体中 μ 受体的一个新的配体结合口袋。此外,δ 型激动剂诱导共表达 μ-和 δ-受体的细胞中 μ 型阿片受体内化,但不诱导仅表达 μ 受体的细胞内化,提示 μ-δ 异源二聚体内化。这种剂量依赖性、百日咳毒素抗性、网格蛋白和动力蛋白依赖性效应需要 μ-和 δ-阿片受体的激动剂占据。与 μ 受体同源二聚体不同,慢性吗啡暴露后,激动剂诱导的 μ-δ 异源二聚体内化持续存在。

结论和意义

μ-δ 受体异源二聚体可能包含一个新的 δ-激动剂检测的高亲和力 μ 受体配体结合口袋,并且在慢性吗啡暴露后,其调节方式与 μ 受体同源二聚体不同。需要占据 μ-和 δ-受体的结合口袋,才能引起 δ-激动剂诱导的 μ-δ 受体异源二聚体内化。δ 型阿片受体激动剂靶向 μ-δ 受体异源二聚体,因此具有比以前鉴定的更广泛的药理学特异性。

相似文献

1
Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.δ 型阿片受体激动剂可改变 μ 型阿片受体激动剂与 μ-δ 型受体异源寡聚体的结合。
Br J Pharmacol. 2010 Nov;161(5):1122-36. doi: 10.1111/j.1476-5381.2010.00944.x.
2
Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.蛋白激酶Cε参与脊髓μ和δ阿片受体协同镇痛相互作用的配体要求。
Br J Pharmacol. 2015 Jan;172(2):642-53. doi: 10.1111/bph.12774. Epub 2014 Nov 24.
3
μ-δ opioid receptor heteromer-specific signaling in the striatum and hippocampus.纹状体和海马体中 μ-δ 阿片受体异源二聚体的特异性信号转导。
Biochem Biophys Res Commun. 2014 Jul 18;450(1):906-11. doi: 10.1016/j.bbrc.2014.06.099. Epub 2014 Jun 26.
4
A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.远端羧基尾在产生μ和δ阿片受体异源寡聚体的新型药理学和G蛋白激活特征方面的作用。
J Biol Chem. 2005 Nov 18;280(46):38478-88. doi: 10.1074/jbc.M505644200. Epub 2005 Sep 13.
5
Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.通过一次高通量筛选鉴定μ-和δ-阿片受体的选择性激动剂和正变构调节剂。
J Biomol Screen. 2014 Oct;19(9):1255-65. doi: 10.1177/1087057114542975. Epub 2014 Jul 21.
6
mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization.μ和δ阿片受体激动剂在不存在受体内化的情况下诱导丝裂原活化蛋白激酶(MAPK)激活。
Neuropharmacology. 2000 Jul 24;39(10):1707-19. doi: 10.1016/s0028-3908(99)00243-9.
7
Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.长期吗啡治疗会改变δ阿片受体内化后的运输过程。
Br J Pharmacol. 2015 Jan;172(2):615-29. doi: 10.1111/bph.12761. Epub 2014 Jul 1.
8
The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.δ 阿片受体激动剂 SNC80 选择性地激活杂二聚体 μ-δ 阿片受体。
ACS Chem Neurosci. 2012 Jul 18;3(7):505-9. doi: 10.1021/cn3000394. Epub 2012 May 22.
9
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.阿片类激动剂对表达克隆人阿片受体的CHO细胞中G蛋白表达的差异作用。
Brain Res Bull. 2008 Sep 5;77(1):49-54. doi: 10.1016/j.brainresbull.2008.05.003. Epub 2008 Jun 4.
10
Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors.临床阿片类药物差异诱导 μ 和 δ 阿片受体共内化。
Mol Pain. 2018 Jan-Dec;14:1744806918769492. doi: 10.1177/1744806918769492. Epub 2018 Mar 27.

引用本文的文献

1
Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.功能失调的异源受体复合物作为治疗重度抑郁和焦虑障碍的新靶点。
Cells. 2022 Jun 2;11(11):1826. doi: 10.3390/cells11111826.
2
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.阿片受体偏向药理学综述:偏向性配体与偏向因子
RSC Med Chem. 2021 Apr 21;12(6):828-870. doi: 10.1039/d1md00041a. eCollection 2021 Jun 23.
3
Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes.内源性μ和δ阿片受体的异源二聚化诱导配体选择性共靶向溶酶体。
Molecules. 2020 Sep 30;25(19):4493. doi: 10.3390/molecules25194493.
4
Receptor-Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis.颈动脉体中G蛋白偶联受体的受体-受体相互作用:一个工作假说。
Front Physiol. 2018 Jun 7;9:697. doi: 10.3389/fphys.2018.00697. eCollection 2018.
5
Dynamic lateral organization of opioid receptors (kappa, mu and mu ) in the plasma membrane at the nanoscale level.阿片受体(κ、μ和μ)在质膜中纳米尺度水平的动态侧向组织。
Traffic. 2018 May 28;19(9):690-709. doi: 10.1111/tra.12582.
6
Synthesis and Investigation of Mixed μ-Opioid and δ-Opioid Agonists as Possible Bivalent Ligands for Treatment of Pain.混合μ-阿片和δ-阿片激动剂作为治疗疼痛的潜在双价配体的合成与研究
J Heterocycl Chem. 2017 Mar;54(2):1228-1235. doi: 10.1002/jhet.2696. Epub 2016 Jun 1.
7
Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.变构机制中的信号传导:G蛋白偶联受体内的信号传递途径
Molecules. 2017 Jul 15;22(7):1188. doi: 10.3390/molecules22071188.
8
Opioids Resistance in Chronic Pain Management.慢性疼痛管理中的阿片类药物耐药性
Curr Neuropharmacol. 2017 Apr;15(3):444-456. doi: 10.2174/1570159X14666161101092822.
9
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.用于治疗慢性疼痛的阿片类药物发现的新型分子策略与靶点
Yale J Biol Med. 2017 Mar 29;90(1):97-110. eCollection 2017 Mar.
10
Molecular Pharmacology of δ-Opioid Receptors.δ-阿片受体的分子药理学
Pharmacol Rev. 2016 Jul;68(3):631-700. doi: 10.1124/pr.114.008979.

本文引用的文献

1
Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.激动剂在 D2 多巴胺受体结合中的协同作用:来自激动剂解离动力学的证据。
J Neurochem. 2010 Mar;112(6):1442-53. doi: 10.1111/j.1471-4159.2009.06554.x. Epub 2009 Dec 24.
2
Guide to Receptors and Channels (GRAC), 4th Edition.《受体与通道指南》(第4版)
Br J Pharmacol. 2009 Nov;158 Suppl 1(Suppl 1):S1-254. doi: 10.1111/j.1476-5381.2009.00499.x.
3
G protein independent phosphorylation and internalization of the delta-opioid receptor.δ-阿片受体的G蛋白非依赖性磷酸化与内化
J Neurochem. 2009 Jun;109(5):1526-35. doi: 10.1111/j.1471-4159.2009.06082.x. Epub 2009 Apr 1.
4
Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors.共表达μ和δ阿片肽受体的CHO细胞中存在μ-δ阿片受体复合物的证据。
Peptides. 2008 Aug;29(8):1424-31. doi: 10.1016/j.peptides.2008.03.019. Epub 2008 Apr 8.
5
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.细胞对慢性阿片类药物的神经适应性变化:耐受性、戒断反应与成瘾
Br J Pharmacol. 2008 May;154(2):384-96. doi: 10.1038/bjp.2008.100. Epub 2008 Apr 14.
6
Galpha-subunits differentially alter the conformation and agonist affinity of kappa-opioid receptors.Gα亚基以不同方式改变κ-阿片受体的构象和激动剂亲和力。
Biochemistry. 2008 Feb 12;47(6):1567-78. doi: 10.1021/bi701476b. Epub 2008 Jan 19.
7
Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.μ和δ阿片受体作为受体-G蛋白融合体的共表达通过不同机制增强了μ和δ信号传导。
J Neurochem. 2008 May;105(3):865-73. doi: 10.1111/j.1471-4159.2008.05215.x. Epub 2008 Jan 7.
8
Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists.预组装的阿片类μ-δ异源寡聚体-Gz信号复合物向质膜的转运:激动剂的协同调节
Biochemistry. 2007 Nov 13;46(45):12997-3009. doi: 10.1021/bi701436w. Epub 2007 Oct 17.
9
Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.受体异二聚化导致信号转导的转换:μ-δ阿片受体异二聚体介导β-抑制蛋白2依赖的细胞外信号调节激酶激活
FASEB J. 2007 Aug;21(10):2455-65. doi: 10.1096/fj.06-7793com. Epub 2007 Mar 23.
10
A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.远端羧基尾在产生μ和δ阿片受体异源寡聚体的新型药理学和G蛋白激活特征方面的作用。
J Biol Chem. 2005 Nov 18;280(46):38478-88. doi: 10.1074/jbc.M505644200. Epub 2005 Sep 13.